NAFTIFINE HYDROCHLORIDE

NAFTIFINE HYDROCHLORIDE was reported 334 times

NAFTIFINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHRONIC RIGHT VENTRICULAR FAILURE 1 0.0270
1 ULNAR NERVE PALSY 1 0.0175
2 AUTONOMIC FAILURE SYNDROME 1 0.0172
3 VICTIM OF SPOUSAL ABUSE 1 0.0156
4 FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III 1 0.0149
5 POLYP COLORECTAL 1 0.0074
6 PULMONARY ENDARTERECTOMY 1 0.0068
7 APPLICATION SITE HYPOAESTHESIA 1 0.0043
8 TINEA CRURIS 2 0.0040
9 BURNING FEET SYNDROME 1 0.0040
10 CHRONIC GASTROINTESTINAL BLEEDING 1 0.0039
11 DUMPING SYNDROME 1 0.0038
12 POST PROCEDURAL BILE LEAK 1 0.0032
13 APPLICATION SITE OEDEMA 1 0.0031
14 ALLERGIC RESPIRATORY SYMPTOM 1 0.0030
15 POST CONCUSSION SYNDROME 1 0.0029
16 APPLICATION SITE PAPULES 3 0.0028
17 WOUND DRAINAGE 2 0.0025
18 NAIL OPERATION 1 0.0024
19 RAPID EYE MOVEMENTS SLEEP ABNORMAL 1 0.0024
20 FUNGAL FOOT INFECTION 1 0.0023
21 CERVICITIS 1 0.0022
22 ROOT CANAL INFECTION 1 0.0020
23 PLASMAPHERESIS 1 0.0019
24 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
25 TINEA PEDIS 3 0.0019
26 HYPERTENSIVE URGENCY 1 0.0018
27 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
28 APPLICATION SITE DISCHARGE 2 0.0017
29 ADENOMYOSIS 1 0.0017
30 SKIN WRINKLING 4 0.0015
31 SKIN HYPERTROPHY 4 0.0014
32 BORDERLINE PERSONALITY DISORDER 1 0.0014
33 CERVICAL RADICULOPATHY 1 0.0014
34 DYSPNOEA PAROXYSMAL NOCTURNAL 1 0.0014
35 BLUNTED AFFECT 1 0.0014
36 REBOUND ACID HYPERSECRETION 4 0.0013
37 GUTTATE PSORIASIS 1 0.0012
38 MYCOSIS FUNGOIDES 1 0.0012
39 NODAL ARRHYTHMIA 1 0.0012
40 ONYCHOMYCOSIS 5 0.0011
41 BONE CONTUSION 1 0.0011
42 NEPHROGENIC ANAEMIA 5 0.0011
43 APPLICATION SITE DERMATITIS 1 0.0011
44 SKIN TEXTURE ABNORMAL 1 0.0010
45 PROSTATE INFECTION 1 0.0010
46 HYPOGONADISM 1 0.0010
47 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 1 0.0010
48 READING DISORDER 2 0.0009
49 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
50 INGROWING NAIL 2 0.0008
51 EMBOLISM ARTERIAL 1 0.0008
52 CHRONIC RESPIRATORY FAILURE 1 0.0008
53 DYSFUNCTIONAL UTERINE BLEEDING 1 0.0008
54 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
55 MALIGNANT MELANOMA IN SITU 1 0.0008
56 TESTICULAR SWELLING 1 0.0008
57 APPLICATION SITE EROSION 1 0.0008
58 GLYCOSURIA 1 0.0007
59 HEAD TITUBATION 1 0.0007
60 RENAL ARTERY STENOSIS 1 0.0007
61 CHRONIC FATIGUE SYNDROME 1 0.0007
62 PERIODONTAL DISEASE 1 0.0007
63 CHORIORETINOPATHY 1 0.0007
64 PELVIC VENOUS THROMBOSIS 1 0.0007
65 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
66 PULMONARY VALVE INCOMPETENCE 1 0.0007
67 ONYCHOLYSIS 1 0.0006
68 METABOLIC ALKALOSIS 1 0.0006
69 SKIN EROSION 2 0.0006
70 VENA CAVA THROMBOSIS 1 0.0006
71 SLEEP TALKING 1 0.0006
72 APPLICATION SITE DRYNESS 2 0.0006
73 BLADDER NEOPLASM 1 0.0006
74 AORTIC STENOSIS 2 0.0006
75 BREAST CYST 1 0.0006
76 PRODUCT TAMPERING 1 0.0006
77 OESOPHAGEAL SPASM 1 0.0005
78 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
79 PURULENCE 1 0.0005
80 NASAL SEPTUM DEVIATION 1 0.0005
81 SKIN ODOUR ABNORMAL 2 0.0005
82 HYPOPHYSITIS 1 0.0005
83 END STAGE RENAL DISEASE 9 0.0005
84 EYELID PAIN 1 0.0005
85 BLISTER 27 0.0005
86 ONYCHOMADESIS 2 0.0005
87 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
88 REACTION TO DRUG EXCIPIENTS 1 0.0005
89 GASTROINTESTINAL ULCER 1 0.0005
90 INFECTIOUS MONONUCLEOSIS 1 0.0004
91 DERMATITIS CONTACT 5 0.0004
92 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
93 APPLICATION SITE SWELLING 2 0.0004
94 TACHYARRHYTHMIA 1 0.0004
95 HYPERPARATHYROIDISM SECONDARY 1 0.0004
96 DIABETIC COMPLICATION 1 0.0004
97 PHYSICAL DECONDITIONING 1 0.0004
98 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
99 ALCOHOL ABUSE 1 0.0004
100 ANORGASMIA 1 0.0004
101 APPLICATION SITE HAEMORRHAGE 1 0.0004
102 RHINALGIA 1 0.0004
103 LUNG CONSOLIDATION 1 0.0004
104 SCAB 4 0.0004
105 HEART VALVE INCOMPETENCE 1 0.0003
106 METABOLIC ENCEPHALOPATHY 1 0.0003
107 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
108 EMBOLISM VENOUS 1 0.0003
109 DIASTOLIC DYSFUNCTION 1 0.0003
110 PRE-EXISTING CONDITION IMPROVED 2 0.0003
111 CHRONIC KIDNEY DISEASE 24 0.0003
112 SKIN EXFOLIATION 26 0.0003
113 FACET JOINT SYNDROME 1 0.0003
114 INFUSION SITE HAEMORRHAGE 1 0.0003
115 OTITIS MEDIA 1 0.0003
116 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
117 POST-TRAUMATIC STRESS DISORDER 2 0.0003
118 B-CELL LYMPHOMA 1 0.0003
119 WOUND COMPLICATION 1 0.0003
120 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
121 APPLICATION SITE REACTION 2 0.0003
122 DIVERTICULUM 2 0.0003
123 VENTRICULAR ARRHYTHMIA 1 0.0003
124 APPLICATION SITE PAIN 6 0.0003
125 ALCOHOL USE 1 0.0003
126 WOUND HAEMORRHAGE 1 0.0003
127 ARTHROPOD BITE 2 0.0003
128 GINGIVAL DISORDER 1 0.0003
129 WOUND SECRETION 1 0.0003
130 NAIL DISCOLOURATION 1 0.0003
131 HYPERLIPIDAEMIA 3 0.0003
132 BLEPHARITIS 1 0.0002
133 APPLICATION SITE EXFOLIATION 1 0.0002
134 SPINAL STENOSIS 1 0.0002
135 LUNG NEOPLASM 1 0.0002
136 PURULENT DISCHARGE 1 0.0002
137 PRODUCT CONTAINER ISSUE 2 0.0002
138 PHYSICAL DISABILITY 1 0.0002
139 BLOOD CREATINE INCREASED 1 0.0002
140 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
141 QUALITY OF LIFE DECREASED 3 0.0002
142 IRON DEFICIENCY 1 0.0002
143 URINE ABNORMALITY 1 0.0002
144 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
145 LOCALISED OEDEMA 1 0.0002
146 COORDINATION ABNORMAL 3 0.0002
147 VAGINAL INFECTION 1 0.0002
148 BLOOD PROLACTIN INCREASED 1 0.0002
149 ENDOMETRIOSIS 1 0.0002
150 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
151 FOOT OPERATION 1 0.0002
152 RENAL INJURY 6 0.0002
153 DIABETIC NEUROPATHY 1 0.0002
154 DRY THROAT 2 0.0002
155 POLYARTHRITIS 1 0.0002
156 OBESITY 3 0.0002
157 BURNING SENSATION 13 0.0002
158 PULMONARY THROMBOSIS 2 0.0002
159 ON AND OFF PHENOMENON 1 0.0002
160 SKIN DISORDER 6 0.0002
161 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
162 STREPTOCOCCAL INFECTION 1 0.0002
163 MACULAR OEDEMA 1 0.0002
164 STATUS EPILEPTICUS 2 0.0002
165 SKIN TOXICITY 1 0.0002
166 SKIN DISCOLOURATION 8 0.0002
167 LOCAL SWELLING 3 0.0002
168 SEXUAL DYSFUNCTION 2 0.0002
169 URINE ODOUR ABNORMAL 1 0.0002
170 GOUT 3 0.0002
171 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
172 NASAL DRYNESS 1 0.0002
173 INFUSION SITE SWELLING 1 0.0002
174 SLEEP APNOEA SYNDROME 3 0.0002
175 PRESCRIBED OVERDOSE 3 0.0002
176 APPLICATION SITE VESICLES 1 0.0002
177 POLYP 1 0.0002
178 APPLICATION SITE ERYTHEMA 4 0.0002
179 HYPOGAMMAGLOBULINAEMIA 1 0.0002
180 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
181 APPETITE DISORDER 1 0.0002
182 SKIN MASS 1 0.0001
183 FULL BLOOD COUNT DECREASED 3 0.0001
184 ULCER HAEMORRHAGE 1 0.0001
185 APPLICATION SITE RASH 2 0.0001
186 LYMPHOEDEMA 1 0.0001
187 RIGHT VENTRICULAR FAILURE 1 0.0001
188 FLUID OVERLOAD 2 0.0001
189 MAJOR DEPRESSION 1 0.0001
190 UTERINE LEIOMYOMA 1 0.0001
191 RENAL FAILURE 18 0.0001
192 HYPERSENSITIVITY 25 0.0001
193 ACIDOSIS 1 0.0001
194 RENAL FAILURE CHRONIC 1 0.0001
195 FOOD ALLERGY 1 0.0001
196 MUSCULOSKELETAL CHEST PAIN 2 0.0001
197 ANKLE FRACTURE 2 0.0001
198 APHTHOUS ULCER 1 0.0001
199 FURUNCLE 1 0.0001
200 STENT PLACEMENT 1 0.0001
201 BACK DISORDER 2 0.0001
202 SHOCK HAEMORRHAGIC 1 0.0001
203 DECUBITUS ULCER 1 0.0001
204 ANHEDONIA 3 0.0001
205 GROIN PAIN 1 0.0001
206 LUNG INFILTRATION 1 0.0001
207 GASTROINTESTINAL INFECTION 1 0.0001
208 HIDRADENITIS 1 0.0001
209 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
210 UROSEPSIS 1 0.0001
211 NERVE COMPRESSION 1 0.0001
212 IRON DEFICIENCY ANAEMIA 1 0.0001
213 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
214 BREAST CANCER STAGE I 1 0.0001
215 NEPHROPATHY 1 0.0001
216 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
217 LACERATION 1 0.0001
218 SQUAMOUS CELL CARCINOMA 1 0.0001
219 LEUKAEMIA 1 0.0001
220 GASTRIC ULCER 2 0.0001
221 PHARYNGEAL SWELLING 1 0.0001
222 ERYTHEMA 21 0.0001
223 RENAL TUBULAR NECROSIS 1 0.0001
224 LIGAMENT SPRAIN 1 0.0001
225 OVARIAN CYST 1 0.0001
226 BRAIN INJURY 1 0.0001
227 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
228 INJURY 7 0.0001
229 CELLULITIS 5 0.0001
230 EYELID PTOSIS 1 0.0001
231 TOOTH ABSCESS 1 0.0001
232 ACUTE KIDNEY INJURY 15 0.0001
233 LIMB DISCOMFORT 3 0.0001
234 TEMPERATURE INTOLERANCE 1 0.0001
235 TENDERNESS 1 0.0001
236 ECZEMA 5 0.0001
237 INJECTION SITE DISCOMFORT 1 0.0001
238 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
239 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
240 BACK INJURY 1 0.0001
241 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
242 FUNGAL INFECTION 3 0.0001
243 SKIN INFECTION 1 0.0001
244 TYPE 2 DIABETES MELLITUS 3 0.0001
245 OCULAR DISCOMFORT 1 0.0001
246 APPLICATION SITE PRURITUS 2 0.0001
247 SKIN IRRITATION 4 0.0001
248 POST PROCEDURAL HAEMORRHAGE 1 0.0001
249 PRURITUS 33 0.0001
250 VASCULITIS 1 0.0001
251 ATAXIA 1 0.0001
252 SKIN BURNING SENSATION 6 0.0001
253 MACULAR DEGENERATION 1 0.0001
254 WRIST FRACTURE 1 0.0001
255 HEPATITIS C 1 0.0001
256 DRY SKIN 11 0.0001
257 NOCTURIA 1 0.0001
258 SCHIZOPHRENIA 1 0.0001
259 FIBROMYALGIA 2 0.0001
260 NO THERAPEUTIC RESPONSE 1 0.0001
261 SPINAL OPERATION 1 0.0001
262 PHARYNGITIS 1 0.0001
263 APPLICATION SITE IRRITATION 1 0.0001
264 DERMATITIS ALLERGIC 1 0.0001
265 ROTATOR CUFF SYNDROME 1 0.0001
266 HIATUS HERNIA 1 0.0001
267 INCORRECT PRODUCT STORAGE 1 0.0001
268 TOOTH INFECTION 1 0.0001
269 SARS-COV-2 TEST POSITIVE 1 0.0001
270 JOINT RANGE OF MOTION DECREASED 1 0.0001
271 PRODUCT TASTE ABNORMAL 1 0.0001
272 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
273 ORAL DISCOMFORT 1 0.0001
274 FEELING COLD 2 0.0001
275 HYPOMAGNESAEMIA 1 0.0001
276 DEVICE OCCLUSION 1 0.0001
277 SEASONAL ALLERGY 1 0.0001
278 DIALYSIS 1 0.0001
279 SUBDURAL HAEMATOMA 1 0.0001
280 PARALYSIS 1 0.0001
281 CARDIOGENIC SHOCK 1 0.0001
282 PARAESTHESIA ORAL 1 0.0001
283 HYPERTHYROIDISM 1 0.0001
284 DYSSTASIA 2 0.0001
285 BRONCHITIS 5 0.0001
286 HAEMORRHAGE 7 0.0001
287 CORONARY ARTERY DISEASE 2 0.0001
288 OSTEOPENIA 1 0.0001
289 NEPHROLITHIASIS 3 0.0001
290 PHARYNGEAL OEDEMA 1 0.0001
291 LUNG INFECTION 1 0.0001
292 BASAL CELL CARCINOMA 1 0.0001
293 PNEUMOTHORAX 1 0.0001
294 RESPIRATORY TRACT CONGESTION 1 0.0001
295 ULCER 1 0.0001
296 PRODUCTIVE COUGH 3 0.0001
297 SCIATICA 1 0.0001
298 ABSCESS 1 0.0001
299 HYPOTHYROIDISM 2 0.0001
300 BLOOD GLUCOSE DECREASED 3 0.0001
301 SENSORY DISTURBANCE 1 0.0001
302 MUSCLE TIGHTNESS 1 0.0001
303 DEEP VEIN THROMBOSIS 4 0.0001
304 VENTRICULAR TACHYCARDIA 1 0.0001
305 EXPIRED PRODUCT ADMINISTERED 2 0.0001
306 URINARY RETENTION 2 0.0001
307 GAIT INABILITY 2 0.0001
308 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
309 SCAR 1 0.0001
310 INFLAMMATION 3 0.0001
311 RASH MACULAR 2 0.0001
312 DEVICE USE ISSUE 1 0.0001
313 COLD SWEAT 1 0.0001
314 SLEEP DISORDER 4 0.0001
315 GASTROENTERITIS VIRAL 1 0.0001
316 OSTEOMYELITIS 1 0.0001
317 DRUG EFFECT INCOMPLETE 2 0.0001
318 HYPERGLYCAEMIA 2 0.0001
319 DYSURIA 2 0.0001
320 BLOOD GLUCOSE ABNORMAL 1 0.0001
321 BACTERIAL INFECTION 1 0.0001
322 EPISTAXIS 4 0.0001
323 RASH 23 0.0001
324 ACNE 4 0.0001
325 BLOOD URINE PRESENT 1 0.0001
326 DIABETES MELLITUS 4 0.0001
327 INCREASED APPETITE 1 0.0001
328 LOWER LIMB FRACTURE 1 0.0001
329 ACUTE RESPIRATORY FAILURE 1 0.0001
330 GLAUCOMA 1 0.0001
331 HERNIA 1 0.0001
332 EAR PAIN 1 0.0001
333 HAEMORRHOIDS 1 0.0001
334 CHOKING 1 0.0001
335 SKIN FISSURES 1 0.0001
336 MENORRHAGIA 1 0.0001
337 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
338 PRODUCT PHYSICAL ISSUE 1 0.0000
339 EMOTIONAL DISTRESS 6 0.0000
340 PULMONARY HYPERTENSION 1 0.0000
341 POLLAKIURIA 2 0.0000
342 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
343 ABDOMINAL DISCOMFORT 8 0.0000
344 BALANCE DISORDER 4 0.0000
345 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
346 FAECES DISCOLOURED 1 0.0000
347 PERIPHERAL SWELLING 7 0.0000
348 TOOTH DISORDER 1 0.0000
349 RASH MACULO-PAPULAR 1 0.0000
350 RASH PAPULAR 1 0.0000
351 SNEEZING 1 0.0000
352 PANCREATITIS ACUTE 1 0.0000
353 ADVERSE EVENT 4 0.0000
354 MUSCLE TWITCHING 1 0.0000
355 PERICARDIAL EFFUSION 1 0.0000
356 SWELLING 4 0.0000
357 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
358 OCULAR HYPERAEMIA 2 0.0000
359 PULMONARY EMBOLISM 4 0.0000
360 PRODUCT PRESCRIBING ERROR 1 0.0000
361 BLOOD PRESSURE FLUCTUATION 1 0.0000
362 DIABETIC KETOACIDOSIS 1 0.0000
363 LOCALISED INFECTION 1 0.0000
364 URINARY TRACT INFECTION 7 0.0000
365 ENCEPHALOPATHY 1 0.0000
366 HYPOAESTHESIA 6 0.0000
367 UNEVALUABLE EVENT 3 0.0000
368 GASTRIC CANCER 1 0.0000
369 HAEMATEMESIS 1 0.0000
370 CARDIOVASCULAR DISORDER 1 0.0000
371 BLOOD PRESSURE INCREASED 6 0.0000
372 ERECTILE DYSFUNCTION 1 0.0000
373 DRUG RESISTANCE 1 0.0000
374 DIPLOPIA 1 0.0000
375 RESPIRATORY TRACT INFECTION 1 0.0000
376 MUSCULOSKELETAL PAIN 2 0.0000
377 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
378 PARAESTHESIA 6 0.0000
379 BLOOD BILIRUBIN INCREASED 1 0.0000
380 DRY MOUTH 3 0.0000
381 RASH PRURITIC 2 0.0000
382 OEDEMA 2 0.0000
383 PNEUMONITIS 1 0.0000
384 TREATMENT NONCOMPLIANCE 2 0.0000
385 SKIN LESION 1 0.0000
386 DIVERTICULITIS 1 0.0000
387 WOUND 1 0.0000
388 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
389 MUSCULAR WEAKNESS 4 0.0000
390 DEPRESSION 8 0.0000
391 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
392 HYPERSOMNIA 1 0.0000
393 EYE IRRITATION 2 0.0000
394 INTENTIONAL PRODUCT MISUSE 3 0.0000
395 URINARY INCONTINENCE 1 0.0000
396 GASTROINTESTINAL DISORDER 3 0.0000
397 IRRITABILITY 2 0.0000
398 APHASIA 1 0.0000
399 OEDEMA PERIPHERAL 4 0.0000
400 DISCOMFORT 2 0.0000
401 SUICIDAL IDEATION 3 0.0000
402 MUSCLE SPASMS 6 0.0000
403 GYNAECOMASTIA 1 0.0000
404 SWOLLEN TONGUE 1 0.0000
405 BONE DENSITY DECREASED 1 0.0000
406 ANXIETY 9 0.0000
407 CYSTITIS 1 0.0000
408 WEIGHT INCREASED 7 0.0000
409 MOVEMENT DISORDER 1 0.0000
410 HIP FRACTURE 1 0.0000
411 RHINORRHOEA 2 0.0000
412 ATRIAL FIBRILLATION 3 0.0000
413 CHOLELITHIASIS 1 0.0000
414 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
415 DEHYDRATION 4 0.0000
416 URTICARIA 5 0.0000
417 EYE PRURITUS 1 0.0000
418 CONDITION AGGRAVATED 9 0.0000
419 HEPATIC ENZYME INCREASED 2 0.0000
420 PAIN 18 0.0000
421 HAEMATURIA 1 0.0000
422 GASTRIC DISORDER 1 0.0000
423 MEMORY IMPAIRMENT 4 0.0000
424 NIGHTMARE 1 0.0000
425 HYPOXIA 1 0.0000
426 HYPERTENSION 6 0.0000
427 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
428 DIARRHOEA 18 0.0000
429 OVERDOSE 6 0.0000
430 CONSTIPATION 6 0.0000
431 INFLUENZA 3 0.0000
432 SEPSIS 3 0.0000
433 DYSARTHRIA 1 0.0000
434 DYSPNOEA EXERTIONAL 1 0.0000
435 INTESTINAL OBSTRUCTION 1 0.0000
436 COLITIS 1 0.0000
437 GAIT DISTURBANCE 5 0.0000
438 PLASMA CELL MYELOMA 1 0.0000
439 PALPITATIONS 3 0.0000
440 DISORIENTATION 1 0.0000
441 THROMBOSIS 2 0.0000
442 SOMNOLENCE 5 0.0000
443 DYSKINESIA 1 0.0000
444 OSTEOPOROSIS 1 0.0000
445 FALL 8 0.0000
446 CARDIO-RESPIRATORY ARREST 1 0.0000
447 ROAD TRAFFIC ACCIDENT 1 0.0000
448 OSTEOARTHRITIS 1 0.0000
449 RENAL FAILURE ACUTE 1 0.0000
450 MYALGIA 4 0.0000
451 RECTAL HAEMORRHAGE 1 0.0000
452 HYPOACUSIS 1 0.0000
453 SEPTIC SHOCK 1 0.0000
454 OFF LABEL USE 20 0.0000
455 MUSCULOSKELETAL STIFFNESS 2 0.0000
456 ANGIOEDEMA 1 0.0000
457 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
458 DEVICE ISSUE 2 0.0000
459 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
460 NEUTROPENIA 3 0.0000
461 DIZZINESS 11 0.0000
462 VISION BLURRED 3 0.0000
463 TINNITUS 1 0.0000
464 BACK PAIN 5 0.0000
465 RENAL DISORDER 1 0.0000
466 BLOOD CHOLESTEROL INCREASED 1 0.0000
467 COGNITIVE DISORDER 1 0.0000
468 COUGH 6 0.0000
469 ARRHYTHMIA 1 0.0000
470 NEUROPATHY PERIPHERAL 2 0.0000
471 COMA 1 0.0000
472 RASH ERYTHEMATOUS 1 0.0000
473 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
474 CONTUSION 2 0.0000
475 HYPOGLYCAEMIA 1 0.0000
476 LUNG DISORDER 1 0.0000
477 PAIN IN EXTREMITY 6 0.0000
478 DRY EYE 1 0.0000
479 SYNCOPE 2 0.0000
480 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
481 FLUID RETENTION 1 0.0000
482 SINUSITIS 2 0.0000
483 THERAPY CESSATION 1 0.0000
484 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
485 HEADACHE 12 0.0000
486 NERVOUSNESS 1 0.0000
487 DISTURBANCE IN ATTENTION 1 0.0000
488 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
489 DRUG INEFFECTIVE 24 0.0000
490 DRUG DOSE OMISSION 3 0.0000
491 HAEMATOCHEZIA 1 0.0000
492 NECK PAIN 1 0.0000
493 THROMBOCYTOPENIA 2 0.0000
494 OXYGEN SATURATION DECREASED 1 0.0000
495 HYPONATRAEMIA 1 0.0000
496 EYE PAIN 1 0.0000
497 CEREBROVASCULAR ACCIDENT 3 0.0000
498 FLATULENCE 1 0.0000
499 RHEUMATOID ARTHRITIS 2 0.0000
500 HERPES ZOSTER 1 0.0000
501 SEIZURE 2 0.0000
502 COVID-19 3 0.0000
503 DYSPHONIA 1 0.0000
504 BONE PAIN 1 0.0000
505 NASAL CONGESTION 1 0.0000
506 CATARACT 1 0.0000
507 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
508 THERAPEUTIC RESPONSE DECREASED 1 0.0000
509 SUICIDE ATTEMPT 1 0.0000
510 ILL-DEFINED DISORDER 1 0.0000
511 PLEURAL EFFUSION 1 0.0000
512 FEELING HOT 1 0.0000
513 NASOPHARYNGITIS 3 0.0000
514 VISUAL IMPAIRMENT 2 0.0000
515 ANAEMIA 3 0.0000
516 SWELLING FACE 1 0.0000
517 PRODUCT DOSE OMISSION 1 0.0000
518 PSORIASIS 2 0.0000
519 DEVICE DIFFICULT TO USE 1 0.0000
520 INFUSION RELATED REACTION 1 0.0000
521 INSOMNIA 4 0.0000
522 THERAPY INTERRUPTED 1 0.0000
523 MOBILITY DECREASED 1 0.0000
524 INFECTION 2 0.0000
525 RESPIRATORY FAILURE 1 0.0000
526 AGITATION 1 0.0000
527 HALLUCINATION 1 0.0000
528 HOSPITALISATION 2 0.0000
529 ARTHRITIS 1 0.0000
530 INJECTION SITE BRUISING 1 0.0000
531 FEELING ABNORMAL 3 0.0000
532 CARDIAC FAILURE CONGESTIVE 1 0.0000
533 PROSTATE CANCER 1 0.0000
534 CONFUSIONAL STATE 2 0.0000
535 PNEUMONIA 4 0.0000
536 CARDIAC ARREST 1 0.0000
537 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
538 TREMOR 2 0.0000
539 ARTHRALGIA 5 0.0000
540 MYOCARDIAL INFARCTION 2 0.0000
541 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
542 DRUG WITHDRAWAL SYNDROME 1 0.0000
543 TACHYCARDIA 1 0.0000
544 ADVERSE DRUG REACTION 1 0.0000
545 OROPHARYNGEAL PAIN 1 0.0000
546 CHEST PAIN 2 0.0000
547 CARDIAC DISORDER 1 0.0000
548 PRODUCT USE ISSUE 2 0.0000
549 ASTHENIA 4 0.0000
550 BLOOD GLUCOSE INCREASED 2 0.0000
551 DYSPNOEA 6 0.0000
552 MIGRAINE 1 0.0000
553 FATIGUE 8 0.0000
554 DYSPEPSIA 1 0.0000
555 HYPOTENSION 2 0.0000
556 FLUSHING 1 0.0000
557 HAEMOGLOBIN DECREASED 1 0.0000
558 ABDOMINAL PAIN UPPER 2 0.0000
559 ILLNESS 1 0.0000
560 ABDOMINAL DISTENSION 1 0.0000
561 ASTHMA 1 0.0000
562 NAUSEA 7 0.0000
563 INCORRECT DOSE ADMINISTERED 2 0.0000
564 PYREXIA 3 0.0000
565 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
566 DECREASED APPETITE 2 0.0000
567 VOMITING 4 0.0000
568 DISEASE PROGRESSION 1 0.0000
569 LOSS OF CONSCIOUSNESS 1 0.0000
570 HYPERHIDROSIS 1 0.0000
571 PRODUCT QUALITY ISSUE 1 0.0000
572 WEIGHT DECREASED 2 0.0000
573 PRODUCT DOSE OMISSION ISSUE 2 0.0000
574 INJECTION SITE PAIN 2 0.0000
575 DRUG INTERACTION 1 0.0000
576 DRUG DEPENDENCE 1 0.0000
577 ALOPECIA 1 0.0000
578 DEATH 4 0.0000
579 MALAISE 2 0.0000